(4-(Benzyloxy)-3-(trifluoromethyl)phenyl)boronic acid, 95.0%, 5g

1H-benzimidazol-1-ylacetonitrile, 95.0%, 2.5g

Methyl quinoxaline-6-carboxylate, 98.0%, 5g

2-Chloro-4-methoxyphenol, 98.0%, 5g

?-Cyclodextrin, 98%, 5kg

Pipetta a spostamento diretto MICROMAN® E, da 100 a 1000 µl, 1 pezzo

2,4-Dimethyl-1H-pyrrole-3-carbonitrile, 95.0%, 50mg

1-tert-Butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 1g

(R)-2-(1-Amino-ethyl)-benzoic acid hydrochloride, 97%, 100mg

Methyl (2R,3R)-2-phenylpyrrolidine-3-carboxylate hydrochloride, 97%, 500mg

Ossido di antimonio(III), ROTI®METIC 99,999% (5N), 25 g, HDPE

Oxazolo[4,5-b]pyridine, 95.0%, 1g

(E)-(4-Methoxystyryl)boronic acid, 98%, 1g